Hepatic resection for metastatic pancreatic cancers - Clinical Trial

What is the Purpose of this Study?

We are doing this study to learn more about if combined surgery of the pancreas and removal of part of the liver is good for patients with stage IV pancreatic cancer who have liver metastases.

What is the Condition Being Studied?

Metastatic Pancreatic Cancer

Who Can Participate in the Study?

- Men and women 18+
- Been diagnosed with pancreatic cancer and have liver metasteses
- People who are able to have surgery

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Have surgery of your pancreas and liver called resection or ablation
- Complete follow-up visits every week for 6-12 weeks, then every 3-4 months for the first year
- After the first year follow-ups with be every 6 months for up to 5 years.

Study Details

Full Title
Hepatic resection for metastatic pancreatic cancers
Principal Investigator
Surgical Oncologist
Protocol Number
IRB: PRO00073208
NCT: NCT02892305
Phase
Phase Pilot
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698